Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gibson

Showing results (551-560 of 577) with videos related to

Pageof 58
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Science Translational Medicine|October 4, 2013
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisJose D Herazo-Maya, Imre Noth, Steven R Duncan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
5-hydroxytryptamine2A receptor inverse agonists as antipsychoticsD M Weiner, E S Burstein, N Nash, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2021
Demonstration of the role of cell wall homeostasis in <i>Staphylococcus aureus</i> growth and the action of bactericidal antibioticsBartłomiej Salamaga, Lingyuan Kong, Laia Pasquina-Lemonche, et al.
Oncotarget|June 17, 2015
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasisJino Park, Michaela Schlederer, Martin Schreiber, et al.
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
The European Respiratory Journal|January 30, 2025
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung diseaseGillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
Plos One|March 5, 2011
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosisJianmin Xue, Bernadette R Gochuico, Ahmad Samer Alawad, et al.
Pageof 58

Showing results (551-560 of 577) with videos related to

Sort By:
Pageof 58
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Science Translational Medicine|October 4, 2013
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosisJose D Herazo-Maya, Imre Noth, Steven R Duncan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
5-hydroxytryptamine2A receptor inverse agonists as antipsychoticsD M Weiner, E S Burstein, N Nash, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2021
Demonstration of the role of cell wall homeostasis in <i>Staphylococcus aureus</i> growth and the action of bactericidal antibioticsBartłomiej Salamaga, Lingyuan Kong, Laia Pasquina-Lemonche, et al.
Oncotarget|June 17, 2015
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasisJino Park, Michaela Schlederer, Martin Schreiber, et al.
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
The European Respiratory Journal|January 30, 2025
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung diseaseGillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
Plos One|March 5, 2011
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosisJianmin Xue, Bernadette R Gochuico, Ahmad Samer Alawad, et al.
Pageof 58